Phase 2 Study of CU104 in Moderate-Severe Ulcerative Colitis
Condition: Ulcerative Colitis Interventions: Drug: CU104; Drug: Placebo Sponsor: Curacle Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials